SCHEMBL21756918

SCHEMBL21756918

CC(C)c1ccc(I)cc1CN

nearest known ligand 0.41

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 1/20 0.38
GABRB1 P18505 1/20 0.38
GABRB2 P47870 1/20 0.38
SLC6A2 P23975 2/20 0.31
TRPA1 O75762 1/20 0.31
LMNA P02545 1/20 0.31
CHRM1 P11229 1/20 0.31
ADRA1A P35348 1/20 0.31
HTR2B P41595 1/20 0.31
SLC6A4 P31645 2/20 0.31
IDO1 P14902 1/20 0.31
CARM1 Q86X55 1/20 0.30
PNMT P11086 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21756915 0.80 GABRA1 (0.42) GABRA1GABRB1GABRB2SLC6A2TRPA1
SCHEMBL21756923 0.78 SLC6A4 (0.46) GABRA1GABRB1GABRB2SLC6A2SLC6A4
SCHEMBL3849204 0.78 SLC6A2 (0.50) SLC6A2TRPA1LMNACHRM1ADRA1A
SCHEMBL26137536 0.78 HTR1D (0.40) GABRA1GABRB2SLC6A2TRPA1LMNA
SCHEMBL21756917 0.77 GABRA1 (0.35) GABRA1GABRB1GABRB2IDO1
SCHEMBL21756948 0.77 SLC6A2 (0.38) GABRA1GABRB1GABRB2SLC6A2SLC6A4
SCHEMBL18926879 0.76 MPO (0.41) SLC6A2SLC6A4IDO1
SCHEMBL3844310 0.76 HTR2B (0.39) GABRA1GABRB1GABRB2SLC6A2TRPA1
SCHEMBL3841008 0.76 LMNA (0.47) GABRA1GABRB1SLC6A2LMNAIDO1
SCHEMBL6861218 0.73 CA1 (0.33) GABRA1GABRB1GABRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020039088-A2 NOVEL COMPOUNDS Xeniopro GmbH (DE) 2020-02-27 WO disclosed
WO-2020039094-A1 PHENOXY(HETERO)ARYL ETHERS OF ANTIPROLIFERATIVE ACTIVITY Xeniopro GmbH (DE) 2020-02-27 WO disclosed
WO-2020039092-A2 NOVEL AROMATIC MOLECULES Xeniopro GmbH (DE) 2020-02-27 WO disclosed
US-9403829-B2 Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-b]pyrazin-2(1H)-one, a solid form thereof and methods of their use SIGNAL PHARMACEUTICALS, LLC (US) 2016-08-02 US disclosed